ArticlePathology oncology research : POR2020

Lactate Dehydrogenase-to-Lymphocyte Ratio Represents a Powerful Prognostic Tool of Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors.

Tao Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.